HONG KONG: Chinese e-commerce giant Alibaba Group Holding Ltd said it's considering whether to launch an appeal against a Hong Kong regulator's finding that it breached takeover rules by buying an effective majority stake in a healthcare firm in 2014 without extending the offer to all of its shareholders.
Alibaba said late on April 25 that the Hong Kong Takeovers and Mergers Panel, part of city's Securities and Futures Commission (SFC) watchdog, found it broke rules by arranging a deal with certain investors in CITIC 21CN, now known as Alibaba Health Information Technology Ltd, at beneficial terms not extended to other shareholders.